Navigation Links
New Research on the Transcatheter Aortic Valve Market Now Available
Date:3/8/2013

DUBLIN, March 8, 2013 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/fhjghw/transcatheter) has announced the addition of the "TransCatheter Aortic Valves Market" report to their offering.

The global transcatheter aortic heart valve opportunity continues to be strong and growing. Edwards reported 2012 sales of $552 and predicts it will manage to generate $780 million globally in 2013, including $420 million in the US alone. Our analysts forecast a $2.2 billion global market by 2018.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)

Interventional cardiologists are exceptionally enthusiastic about the potential of transcatheter aortic valve replacement, and with good reason. The preliminary data on this new treatment modality show that the procedure provides a minimally invasive alternative to cardiac valve surgery.

The average age for patients diagnosed with severe aortic stenosis is 70 years. Traditional valve replacement is considered a high risk surgery for most of these elderly patients.

Furthermore, a significant percentage of patients diagnosed with moderate or severe valve disease have been denied traditional valve surgery, due to its high operative mortality rate.

Transcatheter aortic valve implantation (TAVI) has been established as an alternative to surgical aortic valve replacement in inoperable and high-risk patients with severe, symptomatic aortic stenosis.

Next-generation transcatheter aortic valves will facilitate the procedure, improve outcome and usability and address remaining TAVI-specific drawbacks such as periprosthetic aortic regurgitation.

The TransCatheter Aortic Valves Market report is targeted at senior executives in the medical device industry who wish to get up-to-date with this multi-billion dollar fast growing market. The report offers a consensus-based linear forecast to to 2018.

Key Topics Covered:

1. Executive Summary

2. Aortic Stenosis

3. TransCatheter Aortic Valve Technology

4. TransCatheter Aortic Valves Market

5. The Future of TransCatheter Aortic Valves

6. Company in the Space

List of Tables & Figures:

For more information visit http://www.researchandmarkets.com/research/fhjghw/transcatheter

Research and Markets
Laura Wood , Senior Manager.
press@researchandmarkets.com
U.S. Fax: +1-646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Medical Devices, Cardiovascular Devices


'/>"/>
SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Janssen Launches EXPLORER, Global Cardiovascular Research Program, Beginning with Five New Studies in Patients with Unmet Medical Needs
2. Pipeline Initiatives, Partnerships to Drive Growth - Research Report on Pfizer, Theravance, ISIS Pharmaceuticals, Infinity Pharmaceuticals and Ironwood
3. Accelovance Expansion Continues with Acquisition of Radiant Development, the CRO Division of Radiant Research
4. AVANIR PHARMACEUTICALS ANNOUNCES RESEARCH COLLABORATION WITH DEPARTMENT OF VETERANS AFFAIRS FOR SCREENING PSEUDOBULBAR AFFECT (PBA) SYMPTOMS IN VETERANS WITH TRAUMATIC BRAIN INJURY
5. Todays Research on PDL BioPharma, Dendreon, Medivation, ACADIA Pharma, and Cell Therapeutics
6. Global Gynecological Devices Market is Expected to Reach USD 5.3 Billion by 2018: Transparency Market Research
7. Texas A&M Research Contributes To Improved Ultrasound Imaging
8. Diabetes Research Institute Tests BioHub Mini Organ to Restore Natural Insulin Production in Type 1 Diabetes
9. Presage Biosciences Announces Strategic Research Alliance with Celgene Corporation
10. AMBI Supports Skin of Color Society Research Award
11. Synteract und Harrison Clinical Research vereinbaren die Gründung eines multinationalen Auftragsforschungsinstituts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/7/2017)... , Aug. 7, 2017  Endo International plc (NASDAQ: ... agreements to resolve virtually all known U.S. mesh product ... to resolve the known remaining U.S. claims at reasonable ... beginning in the fourth quarter of 2017 and continuing ... its second quarter 2017 results, the Company intends to ...
(Date:8/2/2017)... Calif. , Aug. 2, 2017 ... Continental Who,s Who as a Pinnacle Lifetime Professional ... the Key Account Manager at Turing Pharmaceuticals, AG. ... negotiations, troubleshooting and relationship building.                ... has more than 25 years of experience as ...
(Date:8/1/2017)... 2017   CerSci Therapeutics , a non-opioid drug ... , has received notice from the National Institute on ... (NIH) that it has been awarded a Direct-to-Phase II ... in 2017 with an additional $1,000,000 to follow in ... application of their lead non-opioid drug candidate CT-044 to ...
Breaking Medicine Technology:
(Date:8/19/2017)... ... August 18, 2017 , ... ... at creating a transparent, verifiable database to help the cannabis industry move towards ... Paragon hopes to deliver a faster technology with lower fees. Paragon will build ...
(Date:8/19/2017)... ... August 19, 2017 , ... Praeclarus Press has ... These illustrations show the diversity of the breastfeeding mothers, using bright colors ... of sizes. These illustrations are also available on tote bags, notepads, smartphone cases, ...
(Date:8/19/2017)... ... August 19, 2017 , ... “Congratulations! It's A Boy! ... children to both their parents and God. “Congratulations! It's A Boy! God’s Gift: A ... a couple from Long Island, New York. , Published by Christian Faith Publishing, Dale ...
(Date:8/18/2017)... York, New York (PRWEB) , ... ... ... International Courier, LLC, d/b/a Quick International, LLC (“Quick”), a highly specialized asset-light ... announced it has entered into a definitive agreement to purchase Unitrans International ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... devices. Through an educational webinar, they will present the line of epMotion automated ... learn how easy you can automate everyday pipetting tasks. , Ideal for scientists ...
Breaking Medicine News(10 mins):